Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Clinical Lung Cancer
|
October 9, 2023
Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression
Cole Friedes, Nikhil Yegya-Raman, Siqi Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 22, 2023
Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors
Cole Friedes, Michelle Iocolano, Sang Ho Lee, et al.
American Journal of Clinical Oncology
|
November 6, 2025
Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant Chemoimmunotherapy
Cole Friedes, Michelle Iocolano, Nikhil Yegya-Raman, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 21, 2021
Association of severe lymphopenia and disease progression in unresectable locally advanced non-small cell lung cancer treated with definitive chemoradiation and immunotherapy
Cole Friedes, Turja Chakrabarti, Sarah Olson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 2, 2026
Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single Institution Series
Lauren Linkowski, Ian Messing, Melanie Berger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 26, 2023
The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC
Cole Friedes, Michelle Iocolano, Sang Ho Lee, et al.
Clinical Lung Cancer
|
January 9, 2024
Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab Consolidation
Adam Barsouk, Cole Friedes, Michelle Iocolano, et al.
Journal of Neuro-Oncology
|
April 25, 2026
Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study
Cole Friedes, Melanie Berger, Lauren Linkowski, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 24, 2023
Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation
Nikhil Yegya-Raman, Cole Friedes, Sang Ho Lee, et al.
Journal for Immunotherapy of Cancer
|
July 10, 2025
Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot study
Steven Joel Feigenberg, Francesca Costabile, Ceylan Tanes, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Clinical Lung Cancer
|
October 9, 2023
Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression
Cole Friedes, Nikhil Yegya-Raman, Siqi Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 22, 2023
Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors
Cole Friedes, Michelle Iocolano, Sang Ho Lee, et al.
American Journal of Clinical Oncology
|
November 6, 2025
Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant Chemoimmunotherapy
Cole Friedes, Michelle Iocolano, Nikhil Yegya-Raman, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 21, 2021
Association of severe lymphopenia and disease progression in unresectable locally advanced non-small cell lung cancer treated with definitive chemoradiation and immunotherapy
Cole Friedes, Turja Chakrabarti, Sarah Olson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 2, 2026
Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single Institution Series
Lauren Linkowski, Ian Messing, Melanie Berger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 26, 2023
The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC
Cole Friedes, Michelle Iocolano, Sang Ho Lee, et al.
Clinical Lung Cancer
|
January 9, 2024
Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab Consolidation
Adam Barsouk, Cole Friedes, Michelle Iocolano, et al.
Journal of Neuro-Oncology
|
April 25, 2026
Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study
Cole Friedes, Melanie Berger, Lauren Linkowski, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 24, 2023
Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation
Nikhil Yegya-Raman, Cole Friedes, Sang Ho Lee, et al.
Journal for Immunotherapy of Cancer
|
July 10, 2025
Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot study
Steven Joel Feigenberg, Francesca Costabile, Ceylan Tanes, et al.
Page
of 4